Alzheimer's Disease: Endosomes

The feed focuses on the role of dysfunctional endosomal trafficking in Alzheimer’s Disease and the potential for targeting the endosome as a therapeutic target.

June 20, 2020

Evidence Linking Protein Misfolding to Quality Control in Progressive Neurodegenerative Diseases

Current Topics in Medicinal Chemistry
Md Tanvir KabirMohamed M Abdel-Daim
July 4, 2020

Intranasal salvinorin A improves neurological outcome in rhesus monkey ischemic stroke model using autologous blood clot

Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism
Longfei WuXunming Ji
June 20, 2020
Open Access

Upregulation of RIN3 induces endosomal dysfunction in Alzheimer's disease

Translational Neurodegeneration
Ruinan ShenChengbiao Wu
June 18, 2020
Review
Open Access

Brain Derived Exosomes Are a Double-Edged Sword in Alzheimer's Disease

Frontiers in Molecular Neuroscience
Zhiqi SongChuan Qin
June 27, 2020
Review
Open Access

MAP/ERK Signaling in Developing Cognitive and Emotional Function and Its Effect on Pathological and Neurodegenerative Processes

International Journal of Molecular Sciences
Héctor Albert-GascóFrancisco E Olucha-Bordonau
July 1, 2020

Prophylactic effect of physical exercise on Aβ1-40 -induced depressive-like behavior and gut dysfunction in mice

Behavioural Brain Research
Julia M RosaAna Lúcia S Rodrigues
July 4, 2020

Regional hyperperfusion in older adults with objectively-defined subtle cognitive decline

Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism
Kelsey R ThomasAlzheimer’s Disease Neuroimaging Initiative
June 27, 2020
Review
Open Access

Sorting Out the Role of the Sortilin-Related Receptor 1 in Alzheimer's Disease

JAD Reports
Karissa BarthelsonMichael Lardelli
June 23, 2020

Seizure protein 6 controls glycosylation and trafficking of kainate receptor subunits GluK2 and GluK3

The EMBO Journal
Martina PigoniStefan F Lichtenthaler
June 20, 2020

Insight into potent leads for alzheimer's disease by using several artificial intelligence algorithms

Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie
Xuedong HeCalvin Yu-Chian Chen
July 7, 2020

Helix Dipole and Membrane Electrostatics Delineate Conformational Transitions in the Self-assembly of Amyloidogenic Peptides

Langmuir : the ACS Journal of Surfaces and Colloids
Qiuchen ZhengNoel D Lazo
June 24, 2020

Amyloid beta, tau, synaptic, neurodegeneration, and glial biomarkers in the preclinical stage of the Alzheimer's continuum

Alzheimer's & Dementia : the Journal of the Alzheimer's Association
Marta Milà-AlomàALFA study
June 26, 2020

Cerebral perfusion is associated with blast exposure in military personnel without moderate or severe TBI

Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism
Danielle R SullivanDavid H Salat

Sign up to follow this feed and discover related papers.

Related Feeds

ALS

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

ALS & FTD: TDP-43

ALS shares with a considerable proportion of FTD cases the same neuropathological substrate, namely, inclusions of abnormally phosphorylated protein tdp-43 (ptdp-43). Here are the latest discoveries pertaining to ptdp-43 and these diseases.

ALS - Pathogenic Mechanisms

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS - Phenotypes

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating phenotypes associated with this genetically heterogeneous disorder.

ALS: Genetics

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here are the latest discoveries pertaining to this disease.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS therapies here.

ALS: Transposon de-silencing

Transposon silencing is a form of transcriptional gene silencing. These gene silencing mechanisms are impaired in Amyotrophic lateral sclerosis (ALS). Here are the latest discoveries pertaining to transposon silencing and this disease.

Age-related Dementia

Age-related dementia (Alzheimer's disease) results from the destructive impact of the pulse on cerebral vasculature. Evidence is reviewed that the neuropathology of the dementia is caused by the breakdown of small cerebral vessels (silent microbleeds), that the microbleeds result from pulse-induced damage to the cerebral vessels, and that pulse becomes increasingly destructive with age, because of the age-related stiffening of the aorta and great arteries, which causes an increase in the intensity of the pressure pulse. Discover the latest research on age-related dementia here.

© 2020 Meta ULC. All rights reserved
/feed-previews/alzheimers-disease-endosomes/4279c856-5cbd-4249-9373-08c6eca0f5a5